ANDA 213524, held by Adaptis. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 213524 (Albuterol Sulfate), held by Adaptis, was first approved by FDA on Oct 8, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 8, 2020 | Original application | Approved | None posted |
| Albuterol SulfateEQ 2MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters